|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/519 | |
| A61K 45/06 | |||
| A61P 35/00 |
| (11) | Number of the document | 2976086 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14768267.8 |
| Date of filing the European patent application | 2014-03-21 | |
| (97) | Date of publication of the European application | 2016-01-27 |
| (45) | Date of publication and mention of the grant of the patent | 2020-10-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/031442 |
| Date | 2014-03-21 |
| (87) | Number | WO 2014/153509 |
| Date | 2014-09-25 |
| (30) | Number | Date | Country code |
| 201361804314 P | 2013-03-22 | US |
| (72) |
BRAKE, Rachel, US
NIU, Huifeng, US
|
| (73) |
Millennium Pharmaceuticals, Inc.,
40 Landsdowne Street, Cambridge, MA 02139,
US
|
| (54) | COMBINATION OF CATALYTIC MTORC 1/2 INHIBITORS AND SELECTIVE INHIBITORS OF AURORA A KINASE |
| COMBINATION OF CATALYTIC MTORC 1/2 INHIBITORS AND SELECTIVE INHIBITORS OF AURORA A KINASE |